ArticleOphthalmology science2026
Test-Retest Repeatability of a Novel Photopic Microperimetry Approach in Patients with Geographic Atrophy.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate test-retest repeatability of novel focal photopic microperimetry approach targeting central 1 mm of the fovea and explore its relationships with geographic atrophy (GA) lesion area and other visual function metrics. Design: A prospective, single arm, observational study. Subjects: Participants with nonsubfoveal GA as determined by spectral-domain OCT and fundus autofluorescence. Methods: Twelve participants (17 eyes) performed focal photopic tests using a 45-loci focal grid (0.5° spacing; Goldmann II stimuli) on Nidek MP-3, along with other visual function assessments. To assess test-retest repeatability of MP-3, 2 tests up to 4 weeks apart were performed. The interval was short relative to expected GA progression, and thus measurements are interpreted as reflecting test-retest repeatability. Main Outcome Measures: Coefficient of repeatability (CoR), intraclass correlation coefficient (ICC), and Bland-Altman were analyzed for mean sensitivity (MS) and point-wise sensitivity (PWS). Correlations of adjusted MS (excluding floor effect) with GA lesion size, best-corrected visual acuity (BCVA), low-luminance visual acuity (LLVA), and contrast sensitivity were also analyzed. Results: Focal photopic MP-3 showed good test-retest repeatability with CoR of MS at 2.42 dB (intraclass correlation coefficient [ICC] = 0.98) and CoR of PWS at 8.2 dB (ICC = 0.89). Excluding the floor effect improved the CoR of MS and PWS to 2.03 dB and 7.06 dB, respectively. Mean test duration was 4.33 minutes per eye with fixation stability >89%. Structure-function analysis showed weak correlation between GA lesion size and adjusted MS ( Conclusions: Focal photopic microperimetry using Goldmann II stimuli provides a highly repeatable measure of central cone-mediated function in patients with nonsubfoveal GA. Mean sensitivity demonstrated high repeatability and supports its use as a robust, clinically relevant endpoint for longitudinal and interventional studies, while PWS may provide spatial information for deeper structure-function analyses. Weak associations with GA lesion size and BCVA suggest that conventional measures may underestimate visual impairment, highlighting the value of focal photopic microperimetry within central 1 mm region as a sensitive, patient-centered outcome in age-related macular degeneration. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.